TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.00$ +1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow TLRY
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-987.1% -9.0% -29.5% -28.7% -108.1% -84.8% -10.5% -28.2% 0.9% -3.9% -11.5% -7.6%
69.1% 8.7% 17.4% 8.9% 8.3% 5.2% 16.0% 24.6% 15.4% 16.1% 16.3% 7.4%
228.8% 4.2% 11.7% 67.5% 44.7% 6.1% 3.4% 5.7% 4.7% 3.0% 2.2% 5.0%
-407.3% -14.6% 15.0% 1.3% -31.8% -39.6% -12.0% -14.6% 1.7% -1.1% -7.6% -9.5%
455.7% 41.0% 4.3% 52.1% 117.3% 24.2% 9.1% 5.4% 2.5% 3.7% 4.0% 3.6%
-550.1% -54.6% -9.1% -56.5% -230.5% -83.2% 10.8% -3.4% -33.8% 16.3% -5.7% -6.1%
1,191.0% 9.6% 0.1%
-1.6% 0.0% -0.2% -0.1% 0.0% 0.0% 0.0%
-19.7% -6.9% -7.8% -2.3% -3.2%
2,785.1% 149.7% 97.2% 58.5% 1,474.7% 37.7% 29.3% 20.4% 8.3% -9.5% 16.3% 14.3%
1,247.9% 86.1% 67.1% -24.9% 1,133.3% -128.3% 92.2% -11.5% -24.8% 2.8% -0.8% 0.8%
-1,442.8% -50.0% -33.9% -80.8% -225.4% -109.0% -19.7% -33.6% -1.5% -7.6% -15.5% -11.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?